Beyond Air (XAIR) Capital Expenditures (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -86.18% |
| Sep 30, 2025 | 24.24% |
| Jun 30, 2025 | -86.78% |
| Mar 31, 2025 | 178.96% |
| Dec 31, 2024 | -54.30% |
| Sep 30, 2024 | -56.04% |
| Jun 30, 2024 | 38.43% |
| Mar 31, 2024 | 44.43% |
| Dec 31, 2023 | -20.51% |
| Sep 30, 2023 | 111.57% |
| Jun 30, 2023 | -60.68% |
| Mar 31, 2023 | 218.93% |
| Dec 31, 2022 | -34.16% |
| Sep 30, 2022 | 273.26% |
| Jun 30, 2022 | -24.56% |
| Mar 31, 2022 | -18.38% |
| Dec 31, 2021 | -29.22% |
| Sep 30, 2021 | 2,092.59% |
| Jun 30, 2021 | 35.00% |
| Mar 31, 2021 | -85.61% |
| Dec 31, 2020 | -71.49% |
| Sep 30, 2020 | 100.17% |
| Jun 30, 2020 | 1,483.09% |
| Mar 31, 2020 | 46.34% |
| Dec 31, 2019 | -28.12% |
| Sep 30, 2019 | 369.92% |
| Jun 30, 2019 | -26.19% |
| Mar 31, 2019 | -73.27% |
| Mar 31, 2018 | -99.54% |
| Dec 31, 2017 | 492.58% |
| Sep 30, 2017 | -19.57% |
| Jun 30, 2017 | 82.50% |